Wang Hui, Huang Zhongmin, Du Chenyan, Dong Mingqing
Geriatric Diseases Institute of Chengdu, Center for Medicine Research and Translation, Chengdu Fifth People's Hospital, 611137 Chengdu, Sichuan, China.
Rev Cardiovasc Med. 2024 Jan 10;25(1):16. doi: 10.31083/j.rcm2501016. eCollection 2024 Jan.
Iron metabolism plays a crucial role in various physiological functions of the human body, as it is essential for the growth and development of almost all organisms. Dysregulated iron metabolism-manifested either as iron deficiency or overload-is a significant risk factor for the development of cardiovascular disease (CVD). Moreover, emerging evidence suggests that ferroptosis, a form of iron-dependent programed cell death, may also contribute to CVD development. Understanding the regulatory mechanisms of iron metabolism and ferroptosis in CVD is important for improving disease management. By integrating different perspectives and expertise in the field of CVD-related iron metabolism, this overview provides insights into iron metabolism and CVD, along with approaches for diagnosing, treating, and preventing CVD associated with iron dysregulation.
Rev Cardiovasc Med. 2024-1-10
Kidney Dis (Basel). 2023-3-15
Oxid Med Cell Longev. 2022
Biochem Pharmacol. 2021-8
Biomed Pharmacother. 2024-7
Biomed Pharmacother. 2023-8
Int J Mol Sci. 2022-11-17
Biomed Pharmacother. 2024-1
Free Radic Biol Med. 2023-10
Nutrients. 2023-5-24
Lancet. 2023-5-27
Haematologica. 2023-5-1
Sci Bull (Beijing). 2021-9-15